Selected Industry Projects
- Antihypertensive agents: amlodipine, ramipril – Phase 3 reports
- Anti-infectives: azithromycin, linezolid – Phase 3 reports, quality control
- Antiplatelet agent: clopidogrel – Phase 1 reports
- Antithrombotic: factor Xa inhibitor – Phase 1 reports
- Breast cancer: fulvestrant – Informed consent document
- Diabetes: troglitazone – Phase 3 reports
- Esophageal cancer: nimotuzumab – Protocol
- Global Innovate!! implementation of progressive business ideas
- Hormone replacement: norethindrone acetate/ethinyl estradiol – Phase 3 reports
- Hypercholesterolemia: torcetrapib / atorvastatin – Phase 2 reports
- Neuropathic pain: gabapentin, pregabalin – Phase 3 reports, safety narratives
- Renal disease: mycophenolate sodium – Protocol
- Selective estrogen receptor modulator (SERM): lasofoxifene – Phase 2/3 reports
- Smoking cessation: varenicline – Phase 3 reports
- Workshops: Clinical Study Reports, GCP, ICH and the Declaration of Helsinki, Informed Consent, Search Strategies, Statistics in Medicine.